{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:28:54Z","timestamp":1761092934717,"version":"build-2065373602"},"reference-count":10,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T00:00:00Z","timestamp":1326758400000},"content-version":"vor","delay-in-days":4368,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:p>A 61\u2010year\u2010old man with atrial fibrillation receiving Coumadin brand warfarin was switched to Barr brand warfarin without his knowledge as a result of a retail pharmacy dispensing error. The patient took the same dosage for 6\u20137 days and experienced severe epistaxis that required two visits to the emergency room. Previously, his coagulation values were within therapeutic range, but when tested at the emergency room the international normalized ratio was elevated. The patient denied changes in therapy compliance, diet, alcohol ingestion, or use of other drugs. His only other drug, taken periodically, was sildenafil for erectile dysfunction. Clinicians should be aware of differences between branded and generic compounds.<\/jats:p>","DOI":"10.1592\/phco.20.3.240.34784","type":"journal-article","created":{"date-parts":[[2004,6,14]],"date-time":"2004-06-14T06:56:42Z","timestamp":1087196202000},"page":"240-243","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epistaxis Associated with Elevation of INR in a Patient Switched to Generic Warfarin"],"prefix":"10.1002","volume":"20","author":[{"given":"Jodianne L.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry A.","family":"Dent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,17]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/ajhp\/55.7.727","article-title":"In favor of Coumadin over generic warfarin","volume":"55","author":"Benson SR","year":"1998","journal-title":"Am J Health-Syst Pharm"},{"key":"e_1_2_1_3_2","first-page":"4B","volume-title":"Managing oral anticoagulation therapy: clinical and operational guidelines","author":"Hansten P.","year":"1998"},{"volume-title":"Viagra (sildenafil) package insert","year":"1999","author":"Pfizer","key":"e_1_2_1_4_2"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1998.tb03919.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1997.tb03741.x"},{"volume-title":"Uniformity of dosage units","year":"1995","author":"United States Pharmacopeia","key":"e_1_2_1_7_2"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/ajhp\/55.7.729","article-title":"Reflections on generic warfarin","volume":"55","author":"Haines ST","year":"1998","journal-title":"Am J Health-Syst Pharm"},{"key":"e_1_2_1_9_2","first-page":"13","article-title":"A blinded, randomized, crossover study comparing the efficacy and safety of generic warfarin sodium to Coumadin","volume":"4","author":"Handler J.","year":"1998","journal-title":"Prevent Cardiol"},{"key":"e_1_2_1_10_2","first-page":"49","article-title":"A randomized crossover study to compare the efficacy and tolerability of Barr warfarin sodium to the currently available Coumadin","volume":"19","author":"Neutel JM","year":"1998","journal-title":"Cardiovasc Rev Rep"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.2.261"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.20.3.240.34784","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.20.3.240.34784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:37:16Z","timestamp":1761039436000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.20.3.240.34784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1592\/phco.20.3.240.34784"],"URL":"https:\/\/doi.org\/10.1592\/phco.20.3.240.34784","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"2012-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}